How big is the immunotherapy market?

Market Analysis and Insights Global Immunotherapy MarketDue to the COVID19 pandemic the global Immunotherapy market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

Global Immunotherapy Market Insights and Forecast to 2028

BUY CHAPTERS

Global Immunotherapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-16U9632

Report

September 2022

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Amgen Inc

Biogen

Bristol–Myers Squibb

Celgene

Johnson & Johnson

Merck

Novartis

Pfizer Inc

Roche

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Immunotherapy estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Immunotherapy is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Immunotherapy is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Immunotherapy is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Immunotherapy include Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis and Pfizer, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Immunotherapy companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Immunotherapy market. Further, it explains the major drivers and regional dynamics of the global Immunotherapy market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Abbvie

Amgen, Inc.

Biogen

Bristol-Myers Squibb

Celgene

Johnson & Johnson

Merck

Novartis

Pfizer

Roche

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Immunotherapy Segment by Type

Monoclonal Antibodies

Therapeutic Vaccines

Checkpoint Inhibitors

Non-Specific Immunotherapy

Immunotherapy Segment by Application

Oncology

Inflammation

Central Nervous System

Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Immunotherapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Immunotherapy market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Immunotherapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immunotherapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immunotherapy revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Immunotherapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Immunotherapy revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis and Pfizer, etc.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immunotherapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Monoclonal Antibodies

1.2.3 Therapeutic Vaccines

1.2.4 Checkpoint Inhibitors

1.2.5 Non-Specific Immunotherapy

1.3 Market by Application

1.3.1 Global Immunotherapy Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Oncology

1.3.3 Inflammation

1.3.4 Central Nervous System

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Immunotherapy Market Size (2017-2028)

2.2 Immunotherapy Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global Immunotherapy Market Size by Region (2017-2022)

2.4 Global Immunotherapy Market Size Forecast by Region (2023-2028)

2.5 Global Top Immunotherapy Countries Ranking by Market Size

3 Immunotherapy Competitive by Company

3.1 Global Immunotherapy Revenue by Players

3.1.1 Global Immunotherapy Revenue by Players (2017-2022)

3.1.2 Global Immunotherapy Market Share by Players (2017-2022)

3.2 Global Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Immunotherapy Revenue

3.4 Global Immunotherapy Market Concentration Ratio

3.4.1 Global Immunotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immunotherapy Revenue in 2021

3.5 Global Immunotherapy Key Players Head office and Area Served

3.6 Key Players Immunotherapy Product Solution and Service

3.7 Date of Enter into Immunotherapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Immunotherapy Breakdown Data by Type

4.1 Global Immunotherapy Historic Revenue by Type (2017-2022)

4.2 Global Immunotherapy Forecasted Revenue by Type (2023-2028)

5 Global Immunotherapy Breakdown Data by Application

5.1 Global Immunotherapy Historic Market Size by Application (2017-2022)

5.2 Global Immunotherapy Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Immunotherapy Revenue by Company (2020-2022)

6.2 North America Immunotherapy Revenue by Type (2017-2028)

6.3 North America Immunotherapy Revenue by Application (2017-2028)

6.4 North America Immunotherapy Revenue by Country (2017-2028)

6.4.1 U.S.

6.4.2 Canada

7 Europe

7.1 Europe Immunotherapy Revenue by Company (2020-2022)

7.2 Europe Immunotherapy Revenue by Type (2017-2028)

7.3 Europe Immunotherapy Revenue by Application (2017-2028)

7.4 Europe Immunotherapy Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8 Asia Pacific

8.1 Asia Pacific Immunotherapy Revenue by Company (2020-2022)

8.2 Asia Pacific Immunotherapy Revenue by Type (2017-2028)

8.3 Asia Pacific Immunotherapy Revenue by Application (2017-2028)

8.4 Asia Pacific Immunotherapy Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

8.4.10 Philippines

8.4.11 Vietnam

9 Latin America

9.1 Latin America Immunotherapy Revenue by Company (2020-2022)

9.2 Latin America Immunotherapy Revenue by Type (2017-2028)

9.3 Latin America Immunotherapy Revenue by Application (2017-2028)

9.4 Latin America Immunotherapy Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Immunotherapy Revenue by Company (2020-2022)

10.2 Middle East and Africa Immunotherapy Revenue by Type (2017-2028)

10.3 Middle East and Africa Immunotherapy Revenue by Application (2017-2028)

10.4 Middle East and Africa Immunotherapy Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 UAE

11 Company Profiles

11.1 Abbvie

11.1.1 Abbvie Company Details

11.1.2 Abbvie Business Overview

11.1.3 Abbvie Immunotherapy Products and Services

11.1.4 Abbvie Immunotherapy Revenue in Immunotherapy Business (2017-2022)

11.1.5 Abbvie Immunotherapy SWOT Analysis

11.1.6 Abbvie Recent Developments

11.2 Amgen, Inc.

11.2.1 Amgen, Inc. Company Details

11.2.2 Amgen, Inc. Business Overview

11.2.3 Amgen, Inc. Immunotherapy Products and Services

11.2.4 Amgen, Inc. Immunotherapy Revenue in Immunotherapy Business (2017-2022)

11.2.5 Amgen, Inc. Immunotherapy SWOT Analysis

11.2.6 Amgen, Inc. Recent Developments

11.3 Biogen

11.3.1 Biogen Company Details

11.3.2 Biogen Business Overview

11.3.3 Biogen Immunotherapy Products and Services

11.3.4 Biogen Immunotherapy Revenue in Immunotherapy Business (2017-2022)

11.3.5 Biogen Immunotherapy SWOT Analysis

11.3.6 Biogen Recent Developments

11.4 Bristol-Myers Squibb

11.4.1 Bristol-Myers Squibb Company Details

11.4.2 Bristol-Myers Squibb Business Overview

11.4.3 Bristol-Myers Squibb Immunotherapy Products and Services

11.4.4 Bristol-Myers Squibb Immunotherapy Revenue in Immunotherapy Business (2017-2022)

11.4.5 Bristol-Myers Squibb Immunotherapy SWOT Analysis

11.4.6 Bristol-Myers Squibb Recent Developments

11.5 Celgene

11.5.1 Celgene Company Details

11.5.2 Celgene Business Overview

11.5.3 Celgene Immunotherapy Products and Services

11.5.4 Celgene Immunotherapy Revenue in Immunotherapy Business (2017-2022)

11.5.5 Celgene Immunotherapy SWOT Analysis

11.5.6 Celgene Recent Developments

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Details

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Immunotherapy Products and Services

11.6.4 Johnson & Johnson Immunotherapy Revenue in Immunotherapy Business (2017-2022)

11.6.5 Johnson & Johnson Immunotherapy SWOT Analysis

11.6.6 Johnson & Johnson Recent Developments

11.7 Merck

11.7.1 Merck Company Details

11.7.2 Merck Business Overview

11.7.3 Merck Immunotherapy Products and Services

11.7.4 Merck Immunotherapy Revenue in Immunotherapy Business (2017-2022)

11.7.5 Merck Immunotherapy SWOT Analysis

11.7.6 Merck Recent Developments

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Immunotherapy Products and Services

11.8.4 Novartis Immunotherapy Revenue in Immunotherapy Business (2017-2022)

11.8.5 Novartis Immunotherapy SWOT Analysis

11.8.6 Novartis Recent Developments

11.9 Pfizer

11.9.1 Pfizer Company Details

11.9.2 Pfizer Business Overview

11.9.3 Pfizer Immunotherapy Products and Services

11.9.4 Pfizer Immunotherapy Revenue in Immunotherapy Business (2017-2022)

11.9.5 Pfizer Immunotherapy SWOT Analysis

11.9.6 Pfizer Recent Developments

11.10 Roche

11.10.1 Roche Company Details

11.10.2 Roche Business Overview

11.10.3 Roche Immunotherapy Products and Services

11.10.4 Roche Immunotherapy Revenue in Immunotherapy Business (2017-2022)

11.10.5 Roche Immunotherapy SWOT Analysis

11.10.6 Roche Recent Developments

12 Immunotherapy Market Dynamics

12.1 Immunotherapy Market Trends

12.2 Immunotherapy Market Drivers

12.3 Immunotherapy Market Challenges

12.4 Immunotherapy Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

FEATURED COMPANIES

AbbVie

Amgen Inc

Biogen

Bristol–Myers Squibb

Celgene

Johnson & Johnson

Merck

Novartis

Pfizer Inc

Roche

List of Tables

Table 1. Global Immunotherapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Therapeutic Vaccines

Table 4. Key Players of Checkpoint Inhibitors

Table 5. Key Players of Non-Specific Immunotherapy

Table 6. Global Immunotherapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 7. Global Immunotherapy Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

Table 8. Global Immunotherapy Revenue by Region (2017-2022) & (US$ Million)

Table 9. Global Immunotherapy Revenue Market Share by Region (2017-2022)

Table 10. Global Immunotherapy Revenue by Players (2017-2022) & (US$ Million)

Table 11. Global Immunotherapy Market Share by Players (2017-2022)

Table 12. Global Top Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy as of 2021)

Table 13. Ranking of Global Top Immunotherapy Companies by Revenue (US$ Million) in 2021

Table 14. Global 5 Largest Players Market Share by Immunotherapy Revenue (CR5 and HHI) & (2017-2022)

Table 15. Key Players Headquarters and Area Served

Table 16. Key Players Immunotherapy Product Solution and Service

Table 17. Date of Key Manufacturers Enter into Immunotherapy Market

Table 18. Mergers & Acquisitions, Expansion Plans

Table 19. Global Immunotherapy Market Size by Type (2017-2022) & (US$ Million)

Table 20. Global Immunotherapy Revenue Market Share by Type (2017-2022)

Table 21. Global Immunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 22. Global Immunotherapy Revenue Market Share by Type (2023-2028)

Table 23. Global Immunotherapy Market Size by Application (2017-2022) & (US$ Million)

Table 24. Global Immunotherapy Revenue Market Share by Application (2017-2022)

Table 25. Global Immunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 26. Global Immunotherapy Revenue Market Share by Application (2023-2028)

Table 27. North America Immunotherapy Revenue by Company (2020-2022) & (US$ Million)

Table 28. North America Immunotherapy Revenue by Type (2017-2022) & (US$ Million)

Table 29. North America Immunotherapy Revenue by Type (2023-2028) & (US$ Million)

Table 30. North America Immunotherapy Revenue by Application (2017-2022) & (US$ Million)

Table 31. North America Immunotherapy Revenue by Application (2023-2028) & (US$ Million)

Table 32. North America Immunotherapy Revenue by Country (2017-2022) & (US$ Million)

Table 33. North America Immunotherapy Revenue by Country (2023-2028) & (US$ Million)

Table 34. Europe Immunotherapy Revenue by Company (2020-2022) & (US$ Million)

Table 35. Europe Immunotherapy Revenue by Type (2017-2022) & (US$ Million)

Table 36. Europe Immunotherapy Revenue by Type (2023-2028) & (US$ Million)

Table 37. Europe Immunotherapy Revenue by Application (2017-2022) & (US$ Million)

Table 38. Europe Immunotherapy Revenue by Application (2023-2028) & (US$ Million)

Table 39. Europe Immunotherapy Revenue by Country (2017-2022) & (US$ Million)

Table 40. Europe Immunotherapy Revenue by Country (2023-2028) & (US$ Million)

Table 41. Asia Pacific Immunotherapy Revenue by Company (2020-2022) & (US$ Million)

Table 42. Asia Pacific Immunotherapy Revenue by Type (2017-2022) & (US$ Million)

Table 43. Asia Pacific Immunotherapy Revenue by Type (2023-2028) & (US$ Million)

Table 44. Asia Pacific Immunotherapy Revenue by Application (2017-2022) & (US$ Million)

Table 45. Asia Pacific Immunotherapy Revenue by Application (2023-2028) & (US$ Million)

Table 46. Asia Pacific Immunotherapy Revenue by Region (2017-2022) & (US$ Million)

Table 47. Asia Pacific Immunotherapy Revenue by Region (2023-2028) & (US$ Million)

Table 48. Latin America Immunotherapy Revenue by Company (2020-2022) & (US$ Million)

Table 49. Latin America Immunotherapy Revenue by Type (2017-2022) & (US$ Million)

Table 50. Latin America Immunotherapy Revenue by Type (2023-2028) & (US$ Million)

Table 51. Latin America Immunotherapy Revenue by Application (2017-2022) & (US$ Million)

Table 52. Latin America Immunotherapy Revenue by Application (2023-2028) & (US$ Million)

Table 53. Latin America Immunotherapy Revenue by Country (2017-2022) & (US$ Million)

Table 54. Latin America Immunotherapy Revenue by Country (2023-2028) & (US$ Million)

Table 55. Middle East and Africa Immunotherapy Revenue by Company (2020-2022) & (US$ Million)

Table 56. Middle East and Africa Immunotherapy Revenue by Type (2017-2022) & (US$ Million)

Table 57. Middle East and Africa Immunotherapy Revenue by Type (2023-2028) & (US$ Million)

Table 58. Middle East and Africa Immunotherapy Revenue by Application (2017-2022) & (US$ Million)

Table 59. Middle East and Africa Immunotherapy Revenue by Application (2023-2028) & (US$ Million)

Table 60. Middle East and Africa Immunotherapy Revenue by Country (2017-2022) & (US$ Million)

Table 61. Middle East and Africa Immunotherapy Revenue by Country (2023-2028) & (US$ Million)

Table 62. Abbvie Company Details

Table 63. Abbvie Business Overview

Table 64. Abbvie Immunotherapy Product and Services

Table 65. Abbvie Immunotherapy Revenue in Immunotherapy Business (2017-2022) & (US$ Million)

Table 66. Abbvie Immunotherapy SWOT Analysis

Table 67. Abbvie Recent Developments

Table 68. Amgen, Inc. Company Details

Table 69. Amgen, Inc. Business Overview

Table 70. Amgen, Inc. Immunotherapy Product and Services

Table 71. Amgen, Inc. Immunotherapy Revenue in Immunotherapy Business (2017-2022) & (US$ Million)

Table 72. Amgen, Inc. Immunotherapy SWOT Analysis

Table 73. Amgen, Inc. Recent Developments

Table 74. Biogen Company Details

Table 75. Biogen Business Overview

Table 76. Biogen Immunotherapy Product and Services

Table 77. Biogen Immunotherapy Revenue in Immunotherapy Business (2017-2022) & (US$ Million)

Table 78. Biogen Immunotherapy SWOT Analysis

Table 79. Biogen Recent Developments

Table 80. Bristol-Myers Squibb Company Details

Table 81. Bristol-Myers Squibb Business Overview

Table 82. Bristol-Myers Squibb Immunotherapy Product and Services

Table 83. Bristol-Myers Squibb Immunotherapy Revenue in Immunotherapy Business (2017-2022) & (US$ Million)

Table 84. Bristol-Myers Squibb Immunotherapy SWOT Analysis

Table 85. Bristol-Myers Squibb Recent Developments

Table 86. Celgene Company Details

Table 87. Celgene Business Overview

Table 88. Celgene Immunotherapy Product and Services

Table 89. Celgene Immunotherapy Revenue in Immunotherapy Business (2017-2022) & (US$ Million)

Table 90. Celgene Immunotherapy SWOT Analysis

Table 91. Celgene Recent Developments

Table 92. Johnson & Johnson Company Details

Table 93. Johnson & Johnson Business Overview

Table 94. Johnson & Johnson Immunotherapy Product and Services

Table 95. Johnson & Johnson Immunotherapy Revenue in Immunotherapy Business (2017-2022) & (US$ Million)

Table 96. Johnson & Johnson Immunotherapy SWOT Analysis

Table 97. Johnson & Johnson Recent Developments

Table 98. Merck Company Details

Table 99. Merck Business Overview

Table 100. Merck Immunotherapy Product and Services

Table 101. Merck Immunotherapy Revenue in Immunotherapy Business (2017-2022) & (US$ Million)

Table 102. Merck Immunotherapy SWOT Analysis

Table 103. Merck Recent Developments

Table 104. Novartis Company Details

Table 105. Novartis Business Overview

Table 106. Novartis Immunotherapy Product and Services

Table 107. Novartis Immunotherapy Revenue in Immunotherapy Business (2017-2022) & (US$ Million)

Table 108. Novartis Immunotherapy SWOT Analysis

Table 109. Novartis Recent Developments

Table 110. Pfizer Company Details

Table 111. Pfizer Business Overview

Table 112. Pfizer Immunotherapy Product and Services

Table 113. Pfizer Immunotherapy Revenue in Immunotherapy Business (2017-2022) & (US$ Million)

Table 114. Pfizer Immunotherapy SWOT Analysis

Table 115. Pfizer Recent Developments

Table 116. Roche Company Details

Table 117. Roche Business Overview

Table 118. Roche Immunotherapy Product and Services

Table 119. Roche Immunotherapy Revenue in Immunotherapy Business (2017-2022) & (US$ Million)

Table 120. Roche Immunotherapy SWOT Analysis

Table 121. Roche Recent Developments

Table 122. Immunotherapy Market Trends

Table 123. Immunotherapy Market Drivers

Table 124. Immunotherapy Market Challenges

Table 125. Immunotherapy Market Restraints

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Immunotherapy Sales Market Share by Type: 2021 VS 2028

Figure 2. Monoclonal Antibodies Features

Figure 3. Therapeutic Vaccines Features

Figure 4. Checkpoint Inhibitors Features

Figure 5. Non-Specific Immunotherapy Features

Figure 6. Global Immunotherapy Sales Market Share by Application: 2021 VS 2028

Figure 7. Oncology Case Studies

Figure 8. Inflammation Case Studies

Figure 9. Central Nervous System Case Studies

Figure 10. Others Case Studies

Figure 11. Immunotherapy Report Years Considered

Figure 12. Global Immunotherapy Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Immunotherapy Market Size 2017-2028 (US$ Million)

Figure 14. Global Immunotherapy Market Size Market Share by Region: 2021 VS 2028

Figure 15. Global Immunotherapy Revenue Market Share by Region in 2017 VS 2022

Figure 16. Global Top 10 Immunotherapy Countries Ranking by Market Size (US$ Million) in 2021

Figure 17. Global Immunotherapy Market Share by Players in 2021

Figure 18. Global Top Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy as of 2021)

Figure 19. The Top 10 and 5 Players Market Share by Immunotherapy Revenue in 2021

Figure 20. North America Immunotherapy Revenue Market Share by Company in 2021

Figure 21. North America Immunotherapy Revenue Market Share by Type (2017-2028)

Figure 22. North America Immunotherapy Revenue Market Share by Application (2017-2028)

Figure 23. North America Immunotherapy Revenue Share by Country (2017-2028)

Figure 24. U.S. Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 25. Canada Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 26. Europe Immunotherapy Revenue Market Share by Company in 2021

Figure 27. Europe Immunotherapy Revenue Market Share by Type (2017-2028)

Figure 28. Europe Immunotherapy Revenue Market Share by Application (2017-2028)

Figure 29. Europe Immunotherapy Revenue Share by Country (2017-2028)

Figure 30. Germany Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 31. France Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 32. U.K. Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 33. Italy Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 34. Russia Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 35. Asia Pacific Immunotherapy Revenue Market Share by Company in 2021

Figure 36. Asia Pacific Immunotherapy Revenue Market Share by Type (2017-2028)

Figure 37. Asia Pacific Immunotherapy Revenue Market Share by Application (2017-2028)

Figure 38. Asia Pacific Immunotherapy Revenue Share by Region (2017-2028)

Figure 39. China Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 40. Japan Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 41. South Korea Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 42. India Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 43. Australia Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 44. Taiwan Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 45. Indonesia Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 46. Thailand Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 47. Malaysia Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 48. Philippines Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 49. Vietnam Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 50. Latin America Immunotherapy Revenue Market Share by Company in 2021

Figure 51. Latin America Immunotherapy Revenue Market Share by Type (2017-2028)

Figure 52. Latin America Immunotherapy Revenue Market Share by Application (2017-2028)

Figure 53. Latin America Immunotherapy Revenue Share by Country (2017-2028)

Figure 54. Mexico Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 55. Brazil Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 56. Argentina Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 57. Middle East and Africa Immunotherapy Revenue Market Share by Company in 2021

Figure 58. Middle East and Africa Immunotherapy Revenue Market Share by Type (2017-2028)

Figure 59. Middle East and Africa Immunotherapy Revenue Market Share by Application (2017-2028)

Figure 60. Middle East and Africa Immunotherapy Revenue Share by Country (2017-2028)

Figure 61. Turkey Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 62. Saudi Arabia Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 63. UAE Immunotherapy Revenue (2017-2028) & (US$ Million)

Figure 64. Abbvie Revenue Growth Rate in Immunotherapy Business (2017-2022)

Figure 65. Amgen, Inc. Revenue Growth Rate in Immunotherapy Business (2017-2022)

Figure 66. Biogen Revenue Growth Rate in Immunotherapy Business (2017-2022)

Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Immunotherapy Business (2017-2022)

Figure 68. Celgene Revenue Growth Rate in Immunotherapy Business (2017-2022)

Figure 69. Johnson & Johnson Revenue Growth Rate in Immunotherapy Business (2017-2022)

Figure 70. Merck Revenue Growth Rate in Immunotherapy Business (2017-2022)

Figure 71. Novartis Revenue Growth Rate in Immunotherapy Business (2017-2022)

Figure 72. Pfizer Revenue Growth Rate in Immunotherapy Business (2017-2022)

Figure 73. Roche Revenue Growth Rate in Immunotherapy Business (2017-2022)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5600

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Immunotherapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published Date: September 2022

Report Code: QYRE-Auto-16U9632

Global Immunotherapy Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

FEATURED COMPANIES

Immunotherapy Segment by Type

Immunotherapy Segment by Application

FEATURED COMPANIES

RELATED REPORTS